Carboprost (Hemabate) for Fibroid Resection

• Status: Recruiting
• Trial end date: 2024-07-01

Summary

The purpose of this research study is to determine if low-dose (i.e., a fraction of what is commonly used) carboprost (Hemabate) helps facilitate fibroid removal (myomectomy).

• Phase: Early Phase 1

Details

• Lead Sponsor: Northwestern University
• Treatments: Carboprost; Carboprost tromethamine